Wegovy In India
- All
- News
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
- Wednesday October 1, 2025
- Health | Written by Shreya Goswami
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
www.ndtv.com
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
- Tuesday September 30, 2025
- Health | Reported by Tanushka Dutta
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
www.ndtv.com
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
- Tuesday July 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
www.ndtv.com/lifestyle
-
Novo Nordisk Launches Weight-Loss Drug 'Wegovy' In India
- Tuesday June 24, 2025
- India News | Reuters
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India.
-
www.ndtv.com
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
- Wednesday October 1, 2025
- Health | Written by Shreya Goswami
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
www.ndtv.com
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
- Tuesday September 30, 2025
- Health | Reported by Tanushka Dutta
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
www.ndtv.com
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
- Tuesday July 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
www.ndtv.com/lifestyle
-
Novo Nordisk Launches Weight-Loss Drug 'Wegovy' In India
- Tuesday June 24, 2025
- India News | Reuters
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India.
-
www.ndtv.com